Viewing nowLipar Tablets 10 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

MFDS item code 201500645 · Approved 2015.02.06 · Insurance code 671704500
Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular diseases (such as myocardial infarction)
This medication helps reduce the risk of cardiovascular disease. Specifically, it lowers the risk of myocardial infarction and stroke in elderly patients, smokers, individuals with hypertension, low HDL cholesterol levels, and adults with a family history. It is also effective in reducing the risk of myocardial infarction and stroke in diabetic patients who have cardiovascular risk factors. For patients with existing coronary artery disease, it effectively reduces the risk of non-fatal myocardial infarction, stroke, vascular procedures, hospitalizations due to congestive heart failure, and angina pectoris. Additionally, it is used to decrease total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels while increasing HDL cholesterol in hyperlipidemia patients. It is particularly useful in preventing cardiovascular diseases in pediatric and adult patients with familial hypercholesterolemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only for patients requiring a reduction in LDL cholesterol of 45 % or more). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Older adults: Efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily.
This medication may cause muscle-related issues. Immediately discontinue use and consult a doctor if symptoms such as muscle pain or weakness occur. In cases of severe muscle pain or suspected muscle damage, a blood test should be conducted to check the extent of muscle damage. Patients with poor liver function or a history of liver disease should not use this medication, and should report any symptoms of liver dysfunction to healthcare providers immediately. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Children under 10 years should not use this drug, while children and adolescents over 10 should use it cautiously under medical supervision. Caution is necessary for those with a history of alcohol dependence or liver disease while taking this medication, and regular liver function tests are recommended. This medication may interact with certain drugs; if other medications are being taken, be sure to inform the doctor or pharmacist. Caution is especially warranted when taking it with certain antibiotics, antifungals, HIV treatments, and grapefruit juice. If symptoms such as muscle pain, muscle weakness, fatigue, or fever occur while taking this medication, inform healthcare providers immediately for testing. This medication contains lactose, so patients with lactose intolerance should not take it. Elderly patients are at higher risk for muscle-related side effects, so they should be more cautious. Patients with impaired kidney function should closely monitor for muscle issues. In the case of overdose, there is no specific antidote, but appropriate treatment according to symptoms should be received, and liver function and muscle-related tests should be performed. Finally, this medication should be stored out of reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be kept in a tightly closed container. It should be stored at room temperature, specifically between 1 and 30 degrees Celsius, to maintain its effectiveness.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.